Paratek Pharmaceuticals Inc SH

13F holders, Q1 2024 (March 31)
2holders
$0.00avg. 13F price*

At the end of Q1 2024, 2 institutions reported holding Paratek Pharmaceuticals Inc SH in their 13F filings. The largest holders were Wetzel Investment Advisors, Inc. ($0) and Clear Point Advisors Inc. ($0).

Company
Paratek Pharmaceuticals Inc SH
CUSIP
699CVR031
Latest filing quarter
Q2 2025

History

Number of 13F holders

012 Q1 2024: 2Q1 2024Q2 2025: 1Q2 2025

Total Exit/New Position Q1 2024

No earlier quarter to compare with.

Ownership 2 holders

Wetzel Investment Advisors, Inc. 0.00% No change 1,000 $0
Clear Point Advisors Inc. 0.00% No change 100 $0

"% of holder's portfolio" is Paratek Pharmaceuticals Inc SH's weight in each manager's 13F, not the share of Paratek Pharmaceuticals Inc SH the manager owns.